Perspective Therapeutics (NYSE:CATX) Earns “Buy” Rating from HC Wainwright
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 410.20% from the company’s previous close. Several other brokerages have also recently […]
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 410.20% from the company’s previous close. Several other brokerages have also recently […]
